Tuesday, May 24, 2011 12:39:45 PM
NEW YORK, March 21, 2011 -- Network CN Inc. (OTCQB: NWCN), a Chinese media company headquartered in Hong Kong, today announced that, since February 23, 2011, the Company’s common stock, along with the securities of over 600 other issuers, has been quoted exclusively on the OTCQB platform maintained by the OTC Markets Group Inc. (the "OTCM"), and is no longer being quoted on the over-the-counter bulletin board ("OTCBB").
The Company’s change from the OTCBB to the OTCQB was not due to the failure of the Company to meet quality standards or any delinquencies in reporting, Rather, certain market makers, including those that have traditionally traded the Company’s common stock, have favored trading on the OTCM platform for their own economic reasons. As a result, the Company’s common stock was automatically dropped from the OTCBB and is now being exclusively quoted on the OTCQB without interruption.
The OTC operates the world’s largest electronic interdealer quotation system for broker-dealers to trade stocks not currently listed on major exchanges such as NASDAQ and NYSE. The OTCQB is a market tier for OTC-traded companies that are registered and reporting with the U.S. Securities and Exchange Commission or a U.S. banking or insurance regulator.
Certain financial web-sites and stock information providers are in the process of updating their platforms to correctly display the trading activity of companies that have transitioned from the OTCBB to the OTCQB. In the interim, accurate price and volume information regarding the Company’s common stock on the OTCQB marketplace is available at
http://www.otcmarkets.com/stock/NWCN/quote.
Recent NWCN News
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/18/2024 02:14:42 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 01/04/2024 11:01:23 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/20/2023 11:01:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 03:57:34 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/28/2023 10:10:12 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/17/2023 09:25:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 02:05:43 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 06/29/2023 12:31:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM